Randomized, Controlled Trial of Hydralazine Versos Nifedipine in Preeclamptic Women with Acute Hypertension

We studied 37 nulliparous women with late-onset gestational hypertension and significant proteinuria, with a diastolic blood pressure of 110 mmHg or higher. They were randomly assigned to receive intravenous hydralazine (5 ou 10 mg) plus an oral placebo; or oral nifedipine (10 or 20 mg) plus an intravenous placebo, with the goal of maintaining diastolic blood pressure at or below 100 mmHg. All drugs were administered in a double-blind fashion. Hydralazine decreased mean arterial pressure from 136± mmHg to 106±7 mmHg, while nifedipine decreased it from 135±8 mmHg to 109±10 mmHg. The incidence of adverse maternal and fetal effects were similar in the two treatment groups. This randomized trial contained a limited number of subjects and, therefore, did not have the statistical power to detect small differences between hydralazine and nifedipine. However, we have demonstrated that a trial of drug therapies for acute hypertension in pregnancy can be successfully blinded, and this approach would be valuable in ...

[1]  S. Lurie,et al.  Nifedipine in the Treatment of Severe Preeclampsia , 1991, Obstetrics and gynecology.

[2]  B. Sibai,et al.  The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term. , 1990, American journal of obstetrics and gynecology.

[3]  M. Whittle,et al.  Effect of nifedipine on Doppler flow velocity waveforms in severe pre-eclampsia. , 1989, BMJ.

[4]  P. Becker,et al.  Nifedipine in acute hypertensive emergencies in pregnancy. , 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  S. Lindow,et al.  The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy , 1988, British journal of obstetrics and gynaecology.

[6]  R. Rochat,et al.  Maternal Mortality in the United States: Report From the Maternal Mortality Collaborative , 1988, Obstetrics and gynecology.

[7]  D. Beevers,et al.  Nifedipine as a second line antihypertensive drug in pregnancy , 1987 .

[8]  M. Read,et al.  The use of a calcium antagonist (nifedipine) to suppress preterm labour , 1986, British journal of obstetrics and gynaecology.

[9]  A. C. D. Tanaka,et al.  Mortalidade materna no Brasil, 1980 , 1984 .

[10]  B. Walters,et al.  Treatment of severe pregnancy‐associated hypertension with the calcium antagonist nifedipine , 1984, British journal of obstetrics and gynaecology.

[11]  K. Andersson,et al.  Effects of nifedipine on human placental arteries. , 1984, Gynecologic and obstetric investigation.

[12]  M. Lindheimer,et al.  Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. , 1981, Medicine.

[13]  S. Chand,et al.  A study of angiotensin II pressor response throughout primigravid pregnancy. , 1973, The Journal of clinical investigation.

[14]  I. Stewart.  Pathogenesis of hypertensive encephalopathy. , 1973, Lancet.

[15]  L. Beilin,et al.  How an acute rise in arterial pressure damages arterioles. Electron microscopic changes during angiotensin infusion. , 1972, Cardiovascular research.

[16]  F. Zuspan,et al.  Renin-angiotensin system in normal and toxemic pregnancies , 1968 .

[17]  W. B. Robertson,et al.  A STUDY OF THE VESSELS OF THE PLACENTAL BED IN NORMOTENSIVE AND HYPERTENSIVE WOMEN , 1958, The Journal of obstetrics and gynaecology of the British Empire.

[18]  J. Hall.  Vascular reactivity and electrolytes in normal and toxemic pregnancy , 1957 .

[19]  W. Raab,et al.  Vascular reactivity and electrolytes in normal and toxemic pregnancy; pathogenic considerations and a diagnostic pre-toxemia test. , 1956, The Journal of clinical endocrinology and metabolism.

[20]  F. Browne.  Sensitization of the Vascular System in Pre‐eclamptic Toxaemia and Eclampsia , 1946, The Journal of obstetrics and gynaecology of the British Empire.

[21]  W. J. Dieckmann,et al.  Vascular-Renal Effects of Posterior Pituitary Extracts in Pregnant Women , 1937 .